loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 202813 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Filters Filter
Cross PopUp
FILTER :

filter

01 TEVA BRANDED PHARM (2)

filter

01 AEROSOL, METERED;NASAL (2)

filter

01 RX (2)

filter

01 QNASL (2)

filter

01 Yes (2)

URL Supplier Web Content
AEROSOL, METERED; ...
0.08MG/ACTUATION
2012-03-23
202813
QNASL
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
AEROSOL, METERED; ...
0.04MG/ACTUATION
2014-12-17
202813
QNASL
RX
Yes
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 202813

Looking for FDA Orange Book APPLICATION 202813 2

19

Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is BECLOMETHASONE DIPROPIONATE, with a corresponding application number 202813.

Regulatory Information RX

With a dosage strength 0.08MG/ACTUATION

Dosage Form Route AEROSOL, METERED; NASAL

Reference Listed Drug Yes

Approved since 2012-03-23

18

Teva Pharmaceutical Industries, based in Israel, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

One of their notable products is BECLOMETHASONE DIPROPIONATE, with a corresponding application number 202813.

Regulatory Information RX

With a dosage strength 0.04MG/ACTUATION

Dosage Form Route AEROSOL, METERED; NASAL

Reference Listed Drug Yes

Approved since 2014-12-17

Post Enquiry
POST ENQUIRY